Published in Thromb Haemost on January 23, 1991
Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun (1992) 1.85
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med (1993) 1.45
Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol (1992) 0.95
Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model. Infect Immun (1993) 0.93
Identification of α2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis. Arthritis Rheumatol (2014) 0.83
Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis. Diagn Microbiol Infect Dis (2016) 0.78
Alpha-2-Macroglobulin Is Acutely Sensitive to Freezing and Lyophilization: Implications for Structural and Functional Studies. PLoS One (2015) 0.75
Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Arthritis Res Ther (2017) 0.75
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis. J Allergy Clin Immunol (1994) 5.14
C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation (1999) 4.40
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Intern Med (1993) 3.42
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest (1989) 3.34
Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84
Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med (1990) 2.82
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood (2000) 2.51
Serum levels of interleukin-6 and acute phase responses. Lancet (1987) 2.44
Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation (1997) 2.41
Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost (2001) 2.38
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood (1990) 2.33
Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med (1999) 2.33
Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol (1992) 2.29
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med (1998) 2.12
Serum inflammatory proteins and cognitive decline in older persons. Neurology (2005) 2.11
[Anaphylactic reactions following insect stings: clinical aspects, course and treatment]. Ned Tijdschr Geneeskd (1993) 1.96
C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation (1997) 1.94
Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord (2007) 1.89
Complement activation plays a key role in the side-effects of rituximab treatment. Br J Haematol (2001) 1.86
Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun (1992) 1.85
Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum (2001) 1.84
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. J Clin Immunol (2001) 1.75
Lactoferrin is a lipid A-binding protein. Infect Immun (1994) 1.73
Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol (2001) 1.70
Proinflammatory effects of IL-10 during human endotoxemia. J Immunol (2000) 1.69
Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation (1997) 1.67
Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost (2001) 1.65
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. Eur Heart J (2002) 1.65
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med (1994) 1.64
Transvascular transport of 67Ga in the lungs after cardiopulmonary bypass surgery. Chest (1993) 1.64
Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax (2004) 1.63
C1-esterase inhibitor substitution in sepsis. Lancet (1992) 1.61
Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? Chest (1998) 1.61
Role of cytokines in sepsis. Adv Immunol (1997) 1.60
Characterization of a hemoglobin protease secreted by the pathogenic Escherichia coli strain EB1. J Exp Med (1998) 1.60
Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59
Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilution. Anesthesiology (1999) 1.57
C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev (2000) 1.52
Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med (1996) 1.52
C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest (2004) 1.50
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
Antithrombin III in patients with severe sepsis: a pharmacokinetic study. Intensive Care Med (2000) 1.49
Acute lung injury after aortic surgery: the relation between lung and leg microvascular permeability to 111indium-labelled transferrin and circulating mediators. Thorax (1997) 1.48
Cardiac tamponade from misplaced central venous line in pericardiophrenic vein. Arch Intern Med (1988) 1.48
Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost (1996) 1.47
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood (1995) 1.47
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med (1993) 1.45
Proteolytic inactivation of alpha 1-antitrypsin and alpha 1-antichymotrypsin by neutrophils in arthritic joints. Arthritis Rheum (1993) 1.44
Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med (1990) 1.43
Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron (1991) 1.41
Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost (2003) 1.41
[Hyperthyroidism induced by iodinated roentgen contrast media]. Ned Tijdschr Geneeskd (1998) 1.40
[Increased frequency of icterus in parenterally fed patients after a change of lipid emulsion]. Ned Tijdschr Geneeskd (1999) 1.40
Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol (1998) 1.39
Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 1.38
Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol (1990) 1.37
Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med (1989) 1.34
Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects. J Immunol (1990) 1.34
Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins. J Immunol Methods (1993) 1.33
ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost (2007) 1.32
A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo. J Immunol (1981) 1.31
Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun (2000) 1.30
Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol (1997) 1.28
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood (1994) 1.28
Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest (1990) 1.27
Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis (1999) 1.26
CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol (1996) 1.26
Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med (2001) 1.26
Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol (2003) 1.25
The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol (1999) 1.24
Time course of cytokine levels in sepsis. Intensive Care Med (1995) 1.22
Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin Exp Immunol (1992) 1.22
Proteolytic inactivation of plasma C1- inhibitor in sepsis. J Clin Invest (1989) 1.22